Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001652130-15-000001
Filing Date
2015-09-03
Accepted
2015-09-03 14:39:04
Documents
1
Effectiveness Date
2015-09-03
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 10499
  Complete submission text file 0001652130-15-000001.txt   11568
Mailing Address 130 BROOKLINE STREET SUITE 201 CAMBRIDGE MA 02139
Business Address 130 BROOKLINE STREET SUITE 201 CAMBRIDGE MA 02139 857-285-6200
Intellia Therapeutics, Inc. (Filer) CIK: 0001652130 (see all company filings)

EIN.: 364785571 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-247004 | Film No.: 151091698